european medicines agency glp-1 vision loss recommendation november 2025 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 EU actions to tackle shortages

Intention-to-treat population

What about drug shortages

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), constitute an escalating worldwide health challenge, with prevalence estimates reaching one-quarter of adults globally

Due to the case volume, we significantly increased our firms healthcare whistleblower practice months ago

For example, a dual synergistic nanoreactor incorporating dihydroquercetin and platinum nanocatalysts within mannose-modified OL-NP demonstrated robust neuroprotection by reducing neuronal injury and modulating microglial activation toward an anti-inflammatory M2 phenotype [299]

doi:10.1172/jci.insight.141851 227